Search research articles
Contact Us
Filters
Showing results (61-70 of 76) with videos related to
Page
of 8
Sort By:
Minerva Urology and Nephrology
|
January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
Carlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Clinical Lung Cancer
|
March 26, 2021
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC
Marco Perna, Vieri Scotti, Patrizia Ciammella, et al.
Frontiers in Oncology
|
October 15, 2021
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Alessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Frontiers in Oncology
|
December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Alessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
The British Journal of Radiology
|
October 9, 2020
Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO)
Pierina Navarria, Giuseppe Minniti, Elena Clerici, et al.
Neuro-Oncology
|
May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
Silvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 76) with videos related to
Sort By:
Page
of 8
Minerva Urology and Nephrology
|
January 13, 2021
Health-related quality of life 24 months after prostate cancer diagnosis: an update from the Pros-IT CNR prospective observational study
Carlotta Palumbo, Alessio Bruni, Alessandro Antonelli, et al.
Clinical Lung Cancer
|
March 26, 2021
The NIPRO Study: An Observational, Retrospective, Multicenter Study on the Safety of the Radiotherapy and Immunotherapy Combination for Advanced-Stage NSCLC
Marco Perna, Vieri Scotti, Patrizia Ciammella, et al.
Frontiers in Oncology
|
October 15, 2021
A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Alessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
Frontiers in Oncology
|
December 6, 2021
Corrigendum: A Real-World, Multicenter, Observational Retrospective Study of Durvalumab After Concomitant or Sequential Chemoradiation for Unresectable Stage III Non-Small Cell Lung Cancer
Alessio Bruni, Vieri Scotti, Paolo Borghetti, et al.
BJR Open
|
March 25, 2024
Stereotactic prostate radiotherapy with or without androgen deprivation therapy, study protocol for a phase III, multi-institutional randomized-controlled trial
Marco Lorenzo Bonù, Alessandro Magli, Davide Tomasini, et al.
World Journal of Urology
|
March 13, 2019
Metastasis-directed stereotactic radiotherapy for oligoprogressive castration-resistant prostate cancer: a multicenter study
Luca Triggiani, Rosario Mazzola, Stefano Maria Magrini, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
May 16, 2020
COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO)
Barbara Alicja Jereczek-Fossa, Matteo Pepa, Giulia Marvaso, et al.
The British Journal of Radiology
|
October 9, 2020
Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO)
Pierina Navarria, Giuseppe Minniti, Elena Clerici, et al.
Neuro-Oncology
|
May 29, 2021
Immunotherapy in association with stereotactic radiotherapy for non-small cell lung cancer brain metastases: results from a multicentric retrospective study on behalf of AIRO
Silvia Scoccianti, Emanuela Olmetto, Valentina Pinzi, et al.
Prostate Cancer and Prostatic Diseases
|
February 19, 2025
Impact of stereotactic body radiotherapy after progression in castrate resistant prostate cancer patients undergoing first line abiraterone treatment. A subgroup analysis from ARTO trial (NCT03449719)
Giulio Francolini, Niccolò Bertini, Vanessa Di Cataldo, et al.
Page
of 8